Daniel Bazarko - Net Worth and Insider Trading
Daniel Bazarko Net Worth
The estimated net worth of Daniel Bazarko is at least $6 Million dollars as of 2024-12-15. Daniel Bazarko is the SVP, Controller, CAO of Alexion Pharmaceuticals Inc and owns about 30,883 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $6 Million. Details can be seen in Daniel Bazarko's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Bazarko has not made any transactions after 2020-12-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel Bazarko
Daniel Bazarko Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Bazarko owns 1 companies in total, including Alexion Pharmaceuticals Inc (ALXN) .
Click here to see the complete history of Daniel Bazarko’s form 4 insider trades.
Insider Ownership Summary of Daniel Bazarko
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2020-12-17 | SVP & Controller & CAO |
Daniel Bazarko Latest Holdings Summary
Daniel Bazarko currently owns a total of 1 stock. Daniel Bazarko owns 30,883 shares of Alexion Pharmaceuticals Inc (ALXN) as of December 17, 2020, with a value of $6 Million.
Latest Holdings of Daniel Bazarko
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2020-12-17 | 30,883 | 182.50 | 5,636,148 |
Holding Weightings of Daniel Bazarko
Daniel Bazarko Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Bazarko has made a total of 1 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 24,066 shares on December 17, 2020, which brought Daniel Bazarko around $4 Million.
Insider Trading History of Daniel Bazarko
- 1
Daniel Bazarko Trading Performance
Daniel Bazarko Ownership Network
Ownership Network List of Daniel Bazarko
Ownership Network Relation of Daniel Bazarko
Daniel Bazarko Owned Company Details
What does Alexion Pharmaceuticals Inc do?
Who are the key executives at Alexion Pharmaceuticals Inc?
Daniel Bazarko is the SVP & Controller & CAO of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include EVP & CCAO Tanisha Carino , EVP & Chief Commercial Officer Brian Goff , and EVP & Research & Development John J Orloff .
Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alexion Pharmaceuticals Inc Insider Transactions
Daniel Bazarko Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Bazarko. You might contact Daniel Bazarko via mailing address: C/o Alexion Pharmaceuticals, Inc. 121 Seaport Boulevard Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
